Advertisement

Circulatory Response to Pressor Agents in Phosphorous Depletion

  • W. Kreusser
  • H. Scholz
  • W. Rascher
  • A. Schömig
  • R. Dietz
  • D. Klormann
  • E. Ritz
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 151)

Abstract

Impaired function of myocardial muscle is a known feature of phosphorous depletion (PD) in man (1,2) and in experimental animals (3). Congestive heart failure has been described in patients, who were chronically phosphorous depleted secondary to ingestion of phosphorous binding agents (2). Furthermore, abnormalities of skeletal muscle function are common in PD (4). However, no information is available on smooth muscle function in PD. Specifically, control of blood pressure and the peripheral response to pressor agents has not been studied.

Keywords

Circulatory Response Skeletal Muscle Function Plasma Noradrenaline Concentration Smooth Muscle Function Extraneuronal Uptake 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    O’Connor, L.R., Wheeler, W.S., Bethune, J.E. (1977), Effect of hypophosphatemia on myocardial performance in man, N.Engl.J.Med. 297: 901PubMedCrossRefGoogle Scholar
  2. 2.
    Darsee, J.R., Nutter, D. (1978), Reversible severe congestive cardiomyopathy in three cases of hypophosphatemia, Ann.Int.Med. 89: 867PubMedGoogle Scholar
  3. 3.
    Fuller, T.J., Nichols, W.W., Brenner, B.J., Peterson, J.C. (1978), Reversible depression in myocardial performance in dogs with experimental phosphorous deficiency, J.Clin.Invest. 62: 1194PubMedCrossRefGoogle Scholar
  4. 4.
    Kretz, J., Sommer, G., Boland, R., Kreusser, W., Hasselbach, W., Ritz, E. (1980), Lack of involvement of sarcoplasmic reticulum in myopathy of acute phosphorous depletion, Klin.Wschr. 58, 833–837PubMedCrossRefGoogle Scholar
  5. 5.
    Hörl, W.H., Kreusser, W., Heidland, A., Ritz, E., Abnormalities of glycogen metabolism in cardiomyopathy of phosphorous depletion, in: “Phosphate and Minerals in Health and Disease”, S.G. Massry, E. Ritz, H. Jahn, ed., Plenum Publishing Corp., New York and London (1980)Google Scholar
  6. 6.
    Kreusser, W., Kurokawa, K., Aznar, E., Massry, S.G. (1978), Phosphate depletion. Effect of renal inorganic phosphorous and adenine nucleotides, urinary phosphate and calcium, and calcium balance, Min. Electr. Metab. 5: 30Google Scholar
  7. 7.
    Folkow, B., Hallbäck, M., Lindgren, Y., Weiss, C. (1970), Background and increased flow resistance and vascular reactivity in spontaneously hypertensive rats, Acta Physiol. Scand. 80: 93PubMedCrossRefGoogle Scholar
  8. 8.
    Schömig, A., Lüth, J.B., Dietz, R., Gross, F. (1976) Changes in vascular smooth muscle sensitivity to vasoconstrictor agents induced by corticosteroids, adrenalectomy and differing salt intake in rats, Clin.Sci.Mol.Med. 51: 61Google Scholar
  9. 9.
    Da Prada, M., Zürcher, G. (1976), Simultaneous ra-dioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range, Life Sciences 19: 1161PubMedCrossRefGoogle Scholar
  10. 10.
    Graefe, K.H., Stefano, F.J.E., Langer, S.Z. (1973), Preferential metabolism of (-)-3H-norepinephrine through the deaminated glycol in the rat vas deferens, Biochem. Pharmacol. 22: 1147CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • W. Kreusser
    • 1
  • H. Scholz
    • 1
  • W. Rascher
    • 1
  • A. Schömig
    • 1
  • R. Dietz
    • 1
  • D. Klormann
    • 1
  • E. Ritz
    • 1
  1. 1.Departments of Internal Medicine and PharmacologyUniversity of HeidelbergGermany

Personalised recommendations